Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 8.285
Filtrer
1.
Mikrochim Acta ; 191(11): 661, 2024 10 10.
Article de Anglais | MEDLINE | ID: mdl-39387990

RÉSUMÉ

By combining boric acid-modified carbon dots (p-CDs) and alizarin red (ARS), a double emission probe p-CDs@ARS with fluorescence at 410 nm and 600 nm is designed for the detection of glyphosate. When Cu2+ is added, it binds with ARS to cause ARS release from p-CDs@ARS, which decreases the fluorescence at 600 nm. However, in the presence of glyphosate, glyphosate competes to the binding of Cu2+, releasing ARS to bind with p-CDs again. Therefore, the fluorescence of 600 nm recovers. Based on this, the fluorescence of 410 nm and 600 nm act as the reference and response signal, respectively, achieving the ratiometric fluorescence detection of glyphosate. The linear range of glyphosate detection is 0.5-50 µM with a limit of detection at 0.37 µM which is well below the maximum residue limit for glyphosate in food. When the probe is used to detect the glyphosate residue in Pearl River water and cucumber, the detection results are well consistent with those detected by HPLC. The established method based on p-CDs@ARS has the advantages that the assembly of ratiometric fluorescence probe is simple, and the detection speed is fast. Additionally, a typical INHIBIT logical system has been successfully constructed based on glyphosate, Cu2+, and the fluorescence signal of p-CDs@ARS.


Sujet(s)
Anthraquinones , Acides boriques , Carbone , Colorants fluorescents , Glycine , Glyphosate , Limite de détection , Boîtes quantiques , Spectrométrie de fluorescence , Glycine/analogues et dérivés , Glycine/analyse , Glycine/composition chimique , Acides boriques/composition chimique , Colorants fluorescents/composition chimique , Carbone/composition chimique , Boîtes quantiques/composition chimique , Spectrométrie de fluorescence/méthodes , Anthraquinones/composition chimique , Cucumis sativus/composition chimique , Polluants chimiques de l'eau/analyse , Herbicides/analyse , Cuivre/composition chimique , Contamination des aliments/analyse
2.
Mar Drugs ; 22(9)2024 Aug 29.
Article de Anglais | MEDLINE | ID: mdl-39330272

RÉSUMÉ

Glioblastoma represents the predominant and a highly aggressive primary neoplasm of the central nervous system that has an abnormal metabolism. Our previous study showed that chrysomycin A (Chr-A) curbed glioblastoma progression in vitro and in vivo. However, whether Chr-A could inhibit orthotopic glioblastoma and how it reshapes metabolism are still unclear. In this study, Chr-A markedly suppressed the development of intracranial U87 gliomas. The results from airflow-assisted desorption electrospray ionization mass spectrometry imaging (AFADESI-MSI) indicated that Chr-A improved the abnormal metabolism of mice with glioblastoma. Key enzymes including glutaminase (GLS), glutamate dehydrogenases 1 (GDH1), hexokinase 2 (HK2) and glucose-6-phosphate dehydrogenase (G6PD) were regulated by Chr-A. Chr-A further altered the level of nicotinamide adenine dinucleotide phosphate (NADPH), thus causing oxidative stress with the downregulation of Nrf-2 to inhibit glioblastoma. Our study offers a novel perspective for comprehending the anti-glioma mechanism of Chr-A, highlighting its potential as a promising chemotherapeutic agent for glioblastoma.


Sujet(s)
Tumeurs du cerveau , Glioblastome , Stress oxydatif , Glioblastome/traitement médicamenteux , Glioblastome/métabolisme , Stress oxydatif/effets des médicaments et des substances chimiques , Animaux , Humains , Souris , Lignée cellulaire tumorale , Tumeurs du cerveau/traitement médicamenteux , Tumeurs du cerveau/métabolisme , Glucose 6-phosphate dehydrogenase/métabolisme , Anthraquinones/pharmacologie , Glutaminase/métabolisme , Facteur-2 apparenté à NF-E2/métabolisme , Évolution de la maladie , Glutamate dehydrogenase/métabolisme , NADP/métabolisme , Tests d'activité antitumorale sur modèle de xénogreffe , Mâle , Souris nude
3.
Front Cell Infect Microbiol ; 14: 1467607, 2024.
Article de Anglais | MEDLINE | ID: mdl-39346899

RÉSUMÉ

Background: The continuous emergence and spread of polymyxin-resistant Acinetobacter baumannii pose a significant global health challenge, necessitating the development of novel therapeutic strategies. Aloe, with its long-standing history of medicinal use, has recently been the subject of substantial research for its efficacy against pathogenic infections. Methods: This study investigates the potential application of anthraquinone components in aloe against polymyxin-resistant A. baumannii by liquid chromatography-mass spectrometry, in vitro activity assessment, and construction of animal infection models. Results: The findings demonstrate that aloe emodin, emodin, rhein, and their mixtures in equal mass ratios (EAR) exhibit strain-specific antibacterial activities against polymyxin-resistant A. baumannii. Co-administration of EAR with EDTA synergistically and universally enhanced the antibacterial activity and bactericidal efficacy of polymyxins against polymyxin-resistant A. baumannii, while also reducing the frequency of polymyxin-resistant mutations in polymyxinssensitive A. baumannii. Following toxicity assessment on human hepatic and renal cell lines, the combination therapy was applied to skin wounds in mice infected with polymyxin-resistant A. baumannii. Compared to monotherapy, the combination therapy significantly accelerated wound healing and reduced bacterial burden. Conclusions: The combination of EAR and EDTA with polymyxins offers a novel therapeutic approach for managing skin infections caused by polymyxinresistant A. baumannii.


Sujet(s)
Infections à Acinetobacter , Acinetobacter baumannii , Aloe , Anthraquinones , Antibactériens , Modèles animaux de maladie humaine , Synergie des médicaments , Acide édétique , Émodine , Tests de sensibilité microbienne , Polymyxines , Acinetobacter baumannii/effets des médicaments et des substances chimiques , Animaux , Anthraquinones/pharmacologie , Anthraquinones/usage thérapeutique , Antibactériens/pharmacologie , Souris , Infections à Acinetobacter/traitement médicamenteux , Infections à Acinetobacter/microbiologie , Émodine/pharmacologie , Émodine/usage thérapeutique , Polymyxines/pharmacologie , Polymyxines/usage thérapeutique , Humains , Acide édétique/pharmacologie , Aloe/composition chimique , Résistance bactérienne aux médicaments , Lignée cellulaire
4.
J Hazard Mater ; 479: 135694, 2024 Nov 05.
Article de Anglais | MEDLINE | ID: mdl-39217944

RÉSUMÉ

Mercury ion (Hg2+) is considered a harmful neurotoxin, and real-time monitoring of Hg2+ concentrations in environmental and biological samples is critical. Fluorescent probes are a rapidly emerging visualization tool owing to their simple design and good selectivity. Herein, a novel fluorescence (FL) probe 2-(4-((6-((quinolin-8-yloxy)methyl)pyridin-2-yl)methyl)piperazin-1-yl)anthracene-9,10-dione (QPPA) is designed using piperazine as a linker between the anthraquinone group, which serves as a fluorophore, and N4O as the Hg2+ ligand. The probe exhibits FL "turn-on" sensing of Hg2+ because the complex inhibits the photo-induced electron transfer (PET) process. Moreover, QPPA can overcome the invasion by other possible cations, resulting in a clear color change from orange to colorless with the addition Hg2+. The chelation of QPPA with Hg2+ in a 1:1 ratio. Subsequently, the theoretically determined binding sites of the ligand to Hg2+ are validated through 1H NMR titration. The in situQPPA-Hg2+ complex can be subjected to Hg2+ extraction following the introduction of S2- owing to its robust binding capacity. The exceptional limit of detection values for Hg2+ and S2- are obtained as 63.0 and 79.1 nM (S/N = 3), respectively. Moreover, QPPA can display bright red FL in the presence of Hg2+ in different biological specimens such as HeLa cells, zebrafish, onion root tip tissues, and water flea Daphnia carinata, further providing an effective strategy for environmental monitoring and bioimaging of Hg2+ in living organisms.


Sujet(s)
Anthraquinones , Colorimétrie , Colorants fluorescents , Mercure , Mercure/analyse , Mercure/composition chimique , Anthraquinones/composition chimique , Animaux , Colorants fluorescents/composition chimique , Colorimétrie/méthodes , Danio zébré , Humains , Daphnia , Fluorimétrie/méthodes , Cellules HeLa , Imagerie optique , Limite de détection
5.
J Enzyme Inhib Med Chem ; 39(1): 2398561, 2024 Dec.
Article de Anglais | MEDLINE | ID: mdl-39223707

RÉSUMÉ

Obesity is acknowledged as a significant risk factor for various metabolic diseases, and the inhibition of human pancreatic lipase (hPL) can impede lipid digestion and absorption, thereby offering potential benefits for obesity treatment. Anthraquinones is a kind of natural and synthetic compounds with wide application. In this study, the inhibitory effects of 31 anthraquinones on hPL were evaluated. The data shows that AQ7, AQ26, and AQ27 demonstrated significant inhibitory activity against hPL, and exhibited selectivity towards other known serine hydrolases. Then the structure-activity relationship between anthraquinones and hPL was further analysed. AQ7 was found to be a mixed inhibition of hPL through inhibition kinetics, while AQ26 and AQ27 were effective non-competitive inhibition of hPL. Molecular docking data revealed that AQ7, AQ26, and AQ27 all could associate with the site of hPL. Developing hPL inhibitors for obesity prevention and treatment could be simplified with this novel and promising lead compound.


Sujet(s)
Anthraquinones , Relation dose-effet des médicaments , Découverte de médicament , Antienzymes , Triacylglycerol lipase , Pancréas , Relation structure-activité , Anthraquinones/pharmacologie , Anthraquinones/composition chimique , Anthraquinones/synthèse chimique , Triacylglycerol lipase/antagonistes et inhibiteurs , Triacylglycerol lipase/métabolisme , Humains , Antienzymes/pharmacologie , Antienzymes/composition chimique , Antienzymes/synthèse chimique , Structure moléculaire , Pancréas/enzymologie , Simulation de docking moléculaire , Produits biologiques/pharmacologie , Produits biologiques/composition chimique , Produits biologiques/synthèse chimique
6.
Ren Fail ; 46(2): 2398710, 2024 Dec.
Article de Anglais | MEDLINE | ID: mdl-39238246

RÉSUMÉ

PURPOSE: This study aimed to investigate the inhibitory effect of chrysophanol on renal fibrosis and its molecular mechanism. METHODS: Initially, potential targets of chrysophanol were predicted through network pharmacology analysis, and a protein-protein interaction network of these targets was constructed using Venn diagrams and the STRING database. GO enrichment analysis predicted the biological process of chrysophanol in treating renal fibrosis. Subsequently, both in vivo and in vitro experiments were conducted using unilateral ureteral obstruction (UUO) induced CKD mouse model and HK-2 cell model, respectively. In the mouse model, different doses of chrysophanol were administered to assess its renal protective effects through biochemical indicators, histological examination, and immunofluorescence staining. In the cell model, the regulatory effect of chrysophanol on the Trx-1/JNK/Cx43 pathway was evaluated using western blotting and flow cytometry. RESULTS: Chrysophanol treatment significantly ameliorated renal dysfunction and histopathological damage in the UUO mouse model, accompanied by a reduction in serum oxidative stress markers. Furthermore, chrysophanol markedly upregulated the expression of Trx-1 in renal tissues and inhibited the activation of the JNK/Cx43 signaling pathway. At the cellular level, chrysophanol enhanced the activity of Trx-1 and downregulated the JNK/Cx43 signaling pathway, thereby inhibiting TGF-ß induced oxidative stress and cell apoptosis. CONCLUSION: This study demonstrated a significant inhibitory effect of chrysophanol on renal fibrosis, mediated by the activation of Trx-1 to inhibit the JNK/Cx43 pathway. These findings provide experimental support for the potential use of chrysophanol as a therapeutic agent for renal fibrosis.


Sujet(s)
Anthraquinones , Modèles animaux de maladie humaine , Fibrose , Rein , Obstruction urétérale , Animaux , Souris , Fibrose/traitement médicamenteux , Mâle , Rein/anatomopathologie , Rein/effets des médicaments et des substances chimiques , Obstruction urétérale/complications , Obstruction urétérale/traitement médicamenteux , Anthraquinones/pharmacologie , Anthraquinones/usage thérapeutique , Humains , Stress oxydatif/effets des médicaments et des substances chimiques , Thiorédoxines/métabolisme , Insuffisance rénale chronique/traitement médicamenteux , Insuffisance rénale chronique/métabolisme , Insuffisance rénale chronique/anatomopathologie , Transduction du signal/effets des médicaments et des substances chimiques , Système de signalisation des MAP kinases/effets des médicaments et des substances chimiques , Lignée cellulaire , Souris de lignée C57BL , Apoptose/effets des médicaments et des substances chimiques
7.
Cardiovasc Toxicol ; 24(11): 1139-1150, 2024 Nov.
Article de Anglais | MEDLINE | ID: mdl-39240427

RÉSUMÉ

Doxorubicin (Dox) has been limited in clinical application due to its cardiac toxicity that varies with the dose. This study aimed to explore how Rhein modulates Dox-induced myocardial toxicity. The general condition and echocardiographic changes of mice were observed to evaluate cardiac function and structure, with myocardial cell injury and apoptosis checked by TUNEL and HE staining. The ELISA assessed markers of myocardial damage and inflammation. The TCMSP and SwissTargetPrediction databases were used to retrieve Rhein's targets while GeneCards was used to find genes related to Dox-induced myocardial injury. Intersection genes were analyzed by Protein-Protein Interaction Networks. The core network genes underwent GO and KEGG enrichment analysis using R software. Western blot was used to detect protein expression. Compared to the Dox group, there was no remarkable difference in heart mass /body mass ratio in the Rhein+Dox group. However, heart mass/tibia length increased. Mice in the Rhein+Dox group had significantly increased LVEF, LVPWs, and LVFS compared to those in the Dox group. Myocardial cell damage, inflammation, and apoptosis significantly reduced in the Rhein+Dox group compared to the model group. Eleven core network genes were selected. Further, Rhein+Dox group showed significantly downregulated expression of p38/p-p38, HSP90AA1, c-Jun/p-c-Jun, c-Fos/p-c-Fos, Bax, and cleaved-caspase-3/caspase-3 while Bcl-2 expression significantly upregulated compared to the Dox group. The study suggests that Rhein mediates cardioprotection against Dox-induced myocardial injury, at least partly, by influencing multiple core genes in the MAPK signaling pathway to inhibit myocardial cell apoptosis.


Sujet(s)
Anthraquinones , Apoptose , Cardiotoxicité , Modèles animaux de maladie humaine , Doxorubicine , Protéines du choc thermique HSP90 , Souris de lignée C57BL , Myocytes cardiaques , Protéines proto-oncogènes c-fos , Protéines proto-oncogènes c-jun , Transduction du signal , p38 Mitogen-Activated Protein Kinases , Animaux , Apoptose/effets des médicaments et des substances chimiques , Anthraquinones/pharmacologie , p38 Mitogen-Activated Protein Kinases/métabolisme , Mâle , Myocytes cardiaques/effets des médicaments et des substances chimiques , Myocytes cardiaques/anatomopathologie , Myocytes cardiaques/métabolisme , Protéines proto-oncogènes c-jun/métabolisme , Protéines proto-oncogènes c-jun/génétique , Protéines du choc thermique HSP90/métabolisme , Protéines du choc thermique HSP90/génétique , Protéines proto-oncogènes c-fos/métabolisme , Protéines proto-oncogènes c-fos/génétique , JNK Mitogen-Activated Protein Kinases/métabolisme , Fonction ventriculaire gauche/effets des médicaments et des substances chimiques , Souris , Protéines régulatrices de l'apoptose/métabolisme , Protéines régulatrices de l'apoptose/génétique , Cardiopathies/induit chimiquement , Cardiopathies/prévention et contrôle , Cardiopathies/anatomopathologie , Cardiopathies/métabolisme , Cartes d'interactions protéiques
8.
Int J Biol Macromol ; 279(Pt 3): 135360, 2024 Nov.
Article de Anglais | MEDLINE | ID: mdl-39242008

RÉSUMÉ

The multi-drug resistance of methicillin-resistant Staphylococcus aureus (MRSA) and complex wound microenvironment challenge the repair of MRSA infected wound. Herein, in this study, α-tocopherol modified glycol chitosan (TG) nanoparticles encapsulated with phytochemical rhein (Rhein@TG NPs) were prepared for comprehensive anti-infection and promotion of MRSA infected wound healing. Rhein@TG NPs could not only specifically release rhein in the infection site in response to low pH and lipase of infectious microenvironment, but also up-regulated M1 macrophage polarization in the infection stage, thus achieving synergistically bacterial elimination with low possibility of developing resistance. Additionally, the NPs reduced the levels of pro-inflammatory factors in the post-infection stage, scavenged the ROS, promoted cell migration and angiogenesis, which significantly improved the microenvironment of infected wound healing. Therefore, this antibiotic-free NPs enabling anti-infection and promotion of wound healing provides a new and long-term strategy for the treatment of MRSA infected wound.


Sujet(s)
Anthraquinones , Antibactériens , Chitosane , Staphylococcus aureus résistant à la méticilline , Nanoparticules , Infections à staphylocoques , Cicatrisation de plaie , Chitosane/composition chimique , Chitosane/pharmacologie , Staphylococcus aureus résistant à la méticilline/effets des médicaments et des substances chimiques , Nanoparticules/composition chimique , Animaux , Cicatrisation de plaie/effets des médicaments et des substances chimiques , Anthraquinones/pharmacologie , Anthraquinones/composition chimique , Anthraquinones/usage thérapeutique , Souris , Antibactériens/pharmacologie , Antibactériens/composition chimique , Antibactériens/administration et posologie , Antibactériens/usage thérapeutique , Infections à staphylocoques/traitement médicamenteux , Infections à staphylocoques/microbiologie , Cellules RAW 264.7 , Infection de plaie/traitement médicamenteux , Infection de plaie/microbiologie , Vecteurs de médicaments/composition chimique
9.
Arch Microbiol ; 206(10): 420, 2024 Sep 27.
Article de Anglais | MEDLINE | ID: mdl-39331181

RÉSUMÉ

The bacterial stringent response is a global regulatory process in which polyphosphate kinase (Ppk) and lon protease are important players. Previous studies have shown that overexpression of the lon gene and deletion of the ppk gene significantly increased actinorhodin production in Streptomyces coelicolor (SCO). In this study, a recombinant SCOΔppk-lon cell, expressing the extra lon gene in Δppk cells, was simulated using a modified in silico (computational) model, ecSco-GEM, and the negative effect of Ppk on actinorhodin production was confirmed. In addition, we identified key enzymes that play a positive role in actinorhodin production. Of these, NADH dehydrogenase/complex-I, beta-ketoacyl-[acyl-carrier-protein] synthase III, glycine cleavage system, and superoxide dismutase were identified as the most significant. By confirming these results with experiments, we have shown that GEMs can be a reliable starting point for in vitro (lab-based) studies of Streptomyces..


Sujet(s)
Anthraquinones , Antibactériens , Protéines bactériennes , Phosphotransferases (Phosphate Group Acceptor) , Protease La , Streptomyces coelicolor , Streptomyces coelicolor/génétique , Streptomyces coelicolor/enzymologie , Streptomyces coelicolor/métabolisme , Protease La/métabolisme , Protease La/génétique , Phosphotransferases (Phosphate Group Acceptor)/métabolisme , Phosphotransferases (Phosphate Group Acceptor)/génétique , Anthraquinones/métabolisme , Antibactériens/biosynthèse , Antibactériens/métabolisme , Protéines bactériennes/génétique , Protéines bactériennes/métabolisme , Régulation de l'expression des gènes bactériens , Benzoisochromanequinones
10.
Chem Biol Drug Des ; 104(3): e14631, 2024 Sep.
Article de Anglais | MEDLINE | ID: mdl-39317695

RÉSUMÉ

To combine the activity characteristics of 18ß-glycyrrhetinic acid (18ß-GA) and anthraquinone compounds (rhein and emodin), reduce toxicity, and explore the structure-activity relationship (SAR) of anthraquinones, 18ß-GA-anthraquinone ester compounds were synthesized by one-step organic synthesis. The products were separated and purified by HPLC and characterized by NMR and EI-MS. It was finally determined as di-18ß-GA-3-rhein ester (1, New), GA dimer (2, known), 18ß-GA-3-emodin ester (3, known), and di-18ß-GA-1-emodin ester (4, new). The MIC of three reactants and four products against Escherichia coli and Staphylococcus aureus were detected in vitro. Its developmental toxicity and cardiotoxicity were assessed using zebrafish embryos. The experimental results showed that rhein had the best antibacterial activity against Staphylococcus aureus with MIC50 of 2.4 mM, and it was speculated that -COOH, -OH, and intramolecular hydrogen bonds in anthraquinone compounds would enhance the antibacterial effect, while the presence of-CH3 might weaken the antibacterial activity. Product 1 increased the hatching rate and survival rate of zebrafish embryos and reduced the malformation rate and cardiomyocyte apoptosis. This experiment lays the foundation for further studying the SAR of anthraquinones and providing new drug candidates.


Sujet(s)
Anthraquinones , Antibactériens , Escherichia coli , Énoxolone , Tests de sensibilité microbienne , Staphylococcus aureus , Danio zébré , Animaux , Anthraquinones/pharmacologie , Anthraquinones/composition chimique , Anthraquinones/synthèse chimique , Antibactériens/pharmacologie , Antibactériens/composition chimique , Antibactériens/synthèse chimique , Énoxolone/pharmacologie , Énoxolone/analogues et dérivés , Énoxolone/composition chimique , Énoxolone/synthèse chimique , Staphylococcus aureus/effets des médicaments et des substances chimiques , Relation structure-activité , Escherichia coli/effets des médicaments et des substances chimiques , Embryon non mammalien/effets des médicaments et des substances chimiques , Esters/composition chimique , Esters/pharmacologie , Esters/synthèse chimique
11.
Chemosphere ; 365: 143360, 2024 Oct.
Article de Anglais | MEDLINE | ID: mdl-39303793

RÉSUMÉ

Anaerobic ammonium oxidizing (anammox) bacteria have been proven weak-electroactive. However, the impact of exogenous anthraquinone-2,6-disulfonate (AQDS) on the anammox activity, although it usually plays essential roles in the life activities of many other electroactive microorganisms, is still unknown. Therefore, this study further explored the influences of AQDS on the anammox activity and the interaction mechanism with anammox bacteria, as well as the behaviors of NH4+, NO2-, and NO3-. The results showed that exogenous AQDS increased the ammonium and total nitrogen removal rates by 12.8% and 10.7%, respectively. Interestingly, the conversion from NO2- to NO3- was significantly reduced after adding AQDS, resulting in a 40.1% reduction in NO3- production of anammox process. In this study, we found for the first time that anammox bacteria could not only carry out the conventional anammox process but also perform a weak redox mediator-mediated anammox process, which could achieve the 1:1 consumption of NH4+ and NO2-. The redox mediator-mediated anammox process was related to an endogenous redox mediator (ERM) synthesized and secreted by anammox bacteria, whose redox midpoint potential was around -0.26 V (vs. Ag/AgCl). After adding AQDS, not only the ERM-mediated anammox process was enhanced, but also two novel redox mediator-mediated anammox processes were introduced, including the AQDS-mediated anammox process and ERM-AQDS-mediated anammox process. These three redox mediator-mediated anammox processes significantly improved the nitrogen removal performance of anammox bacteria and reduced energy consumption. These findings will help reduce the dependence of anammox technology on NO2-, reduce the cost of subsequent treatment of NO3-, and provide new visions for optimizing and applying anammox technology.


Sujet(s)
Composés d'ammonium , Azote , Oxydoréduction , Eaux d'égout , Élimination des déchets liquides , Azote/métabolisme , Eaux d'égout/microbiologie , Composés d'ammonium/métabolisme , Anaérobiose , Élimination des déchets liquides/méthodes , Anthraquinones/métabolisme , Bactéries/métabolisme , Bioréacteurs/microbiologie
12.
Mar Drugs ; 22(9)2024 Aug 24.
Article de Anglais | MEDLINE | ID: mdl-39330261

RÉSUMÉ

Antimicrobial resistance is a critical global health issue, with rising resistance among bacteria and fungi. Marine organisms have emerged as promising, but underexplored, sources of new antimicrobial agents. Among them, marine polychaetes, such as Halla parthenopeia, which possess chemical defenses, could attract significant research interest. This study explores the antimicrobial properties of hallachrome, a unique anthraquinone found in the purple mucus of H. parthenopeia, against Gram-negative bacteria (Escherichia coli ATCC 25922, Pseudomonas aeruginosa ATCC 9027), Gram-positive bacteria (Enterococcus faecalis ATCC 29212, Staphylococcus aureus ATCC 6538, Staphylococcus epidermidis ATCC 12228), and the most common human fungal pathogen Candida albicans ATCC 10231. Antibacterial susceptibility testing revealed that Gram-negative bacteria were not inhibited by hallachrome at concentrations ≤2 mM. However, Gram-positive bacteria showed significant growth inhibition at 0.12-0.25 mM, while C. albicans was inhibited at 0.06 mM. Time-kill studies demonstrated dose-dependent growth inhibition of susceptible strains by hallachrome, which exerted its effect by altering the membrane permeability of C. albicans, E. faecalis, and S. epidermidis after 6 h and S. aureus after 24 h. Additionally, hallachrome significantly reduced biofilm formation and mature biofilm in S. aureus, E. faecalis, and C. albicans. Additionally, it inhibited hyphal growth in C. albicans. These findings highlight hallachrome's potential as a novel antimicrobial agent, deserving further exploration for clinical experimentation.


Sujet(s)
Anthraquinones , Candida albicans , Tests de sensibilité microbienne , Polychaeta , Candida albicans/effets des médicaments et des substances chimiques , Animaux , Anthraquinones/pharmacologie , Anthraquinones/composition chimique , Anthraquinones/isolement et purification , Bactéries à Gram positif/effets des médicaments et des substances chimiques , Anti-infectieux/pharmacologie , Anti-infectieux/composition chimique , Antibactériens/pharmacologie , Antibactériens/composition chimique , Antibactériens/isolement et purification , Bactéries à Gram négatif/effets des médicaments et des substances chimiques , Organismes aquatiques , Biofilms/effets des médicaments et des substances chimiques
13.
Microb Cell Fact ; 23(1): 234, 2024 Aug 24.
Article de Anglais | MEDLINE | ID: mdl-39182107

RÉSUMÉ

BACKGROUND: Several two-component systems of Streptomyces coelicolor, a model organism used for studying antibiotic production in Streptomyces, affect the expression of the bfr (SCO2113) gene that encodes a bacterioferritin, a protein involved in iron storage. In this work, we have studied the effect of the deletion mutant ∆bfr in S. coelicolor. RESULTS: The ∆bfr mutant exhibits a delay in morphological differentiation and produces a lesser amount of the two pigmented antibiotics (actinorhodin and undecylprodigiosin) compared to the wild type on complex media. The effect of iron in minimal medium was tested in the wild type and ∆bfr mutant. Consequently, we also observed different levels of production of the two pigmented antibiotics between the two strains, depending on the iron concentration and the medium (solid or liquid) used. Contrary to expectations, no differences in intracellular iron concentration were detected between the wild type and ∆bfr mutant. However, a higher level of reactive oxygen species in the ∆bfr mutant and a higher tolerance to oxidative stress were observed. Proteomic analysis showed no variation in iron response proteins, but there was a lower abundance of proteins related to actinorhodin and ribosomal proteins, as well as others related to secondary metabolite production and differentiation. Additionally, a higher abundance of proteins related to various types of stress, such as respiration and hypoxia among others, was also revealed. Data are available via ProteomeXchange with identifier PXD050869. CONCLUSION: This bacterioferritin in S. coelicolor (Bfr) is a new element in the complex regulation of secondary metabolism in S. coelicolor and, additionally, iron acts as a signal to modulate the biosynthesis of active molecules. Our model proposes an interaction between Bfr and iron-containing regulatory proteins. Thus, identifying these interactions would provide new information for improving antibiotic production in Streptomyces.


Sujet(s)
Anthraquinones , Antibactériens , Protéines bactériennes , Ferritines , Fer , Streptomyces coelicolor , Streptomyces coelicolor/métabolisme , Streptomyces coelicolor/génétique , Streptomyces coelicolor/croissance et développement , Antibactériens/biosynthèse , Antibactériens/métabolisme , Ferritines/métabolisme , Ferritines/génétique , Protéines bactériennes/métabolisme , Protéines bactériennes/génétique , Fer/métabolisme , Anthraquinones/métabolisme , Cytochromes de type b/métabolisme , Cytochromes de type b/génétique , Régulation de l'expression des gènes bactériens , Prodigiosine/métabolisme , Prodigiosine/analogues et dérivés , Prodigiosine/biosynthèse , Espèces réactives de l'oxygène/métabolisme , Protéomique , Benzoisochromanequinones
14.
Environ Sci Pollut Res Int ; 31(42): 54832-54853, 2024 Sep.
Article de Anglais | MEDLINE | ID: mdl-39215915

RÉSUMÉ

In this study, Ag2CrO4@NiFe-LDH nanoparticles were synthesized by hydrothermal method for photocatalytic degradation of Alizarin Red (AR) dye. Three composites with different molar percentages were prepared, among which 50%Ag2CrO4@50%NiFe-LDH composite was the best sample with a removal rate of 97.1% in AR degradation. Also, the properties, structure, and characteristics of pure Ag2CrO4 and NiFe-LDH and their composites were determined by XRD, FESEM, FTIR, EDX mapping, and UV-visible analyses. It was found that Ag2CrO4@NiFe-LDH composites with the formation of heterogeneous structure of Z-scheme, in addition to increasing the active sites and increasing the specific surface, decrease the recombination rate of pure Ag2CrO4 and NiFe-LDH. Also, the Box-Behnken design technique, which is one of the most common designs used in response surface methodology, was used to optimize the operating conditions and investigate the effect of 4 independent parameters: catalyst amount, solution concentration, pH, and light intensity. The importance of independent parameters and their interactions were determined by ANOVA. By means of numerical optimization, the optimal values of the selected parameters equal to 1.34 g/L of catalyst, concentration of 16.45 mg/L, pH = 10.74, and light intensity of 15.53 W were obtained as optimal conditions with a desirability coefficient of 1.00 and an absorption value of 89.34%. The closeness of adjusted R2 (0.9838) and predicted R2 (0.9507) values show that this model can be successfully used for prediction.


Sujet(s)
Anthraquinones , Lumière , Anthraquinones/composition chimique , Catalyse , Polluants chimiques de l'eau/composition chimique
15.
PLoS One ; 19(8): e0308684, 2024.
Article de Anglais | MEDLINE | ID: mdl-39121077

RÉSUMÉ

The biosynthetic pathway of actinorhodin in Streptomyces coelicolor A3(2) has been studied for decades as a model system of type II polyketide biosynthesis. The actinorhodin biosynthetic gene cluster includes a gene, actVI-orfA, that encodes a protein that belongs to the nuclear transport factor-2-like (NTF-2-like) superfamily. The function of this ActVI-ORFA protein has been a long-standing question in this field. Several hypothetical functions, including pyran ring cyclase, enzyme complex stability enhancer, and gene transcription regulator, have been proposed for ActVI-ORFA in previous studies. However, although the recent structural analysis of ActVI-ORFA revealed a solvent-accessible cavity, the protein displayed structural differences to the well-characterized cyclase SnoaL and did not possess a DNA-binding domain. The obtained crystal structure facilitates an inspection of the previous hypotheses regarding the function of ActVI-ORFA. In the present study, we investigated the effects of a series of actVI-orfA test plasmids with different mutations in an established vector/host system. Time-course analysis of dynamic metabolism profiles demonstrated that ActVI-ORFA prevented formation of shunt metabolites and may have a metabolic flux directing function, which shepherds the flux of unstable intermediates towards actinorhodin. The expression studies resulted in the isolation and structure elucidation of two new shunt metabolites from the actinorhodin pathway. Next, we utilized computational modeling to probe the active site of ActVI-ORFA and confirmed the importance of residues R76 and H78 in the flux directing functionality by expression studies. This is the first time such a function has been observed for a member of NTF-2-like superfamily in Streptomyces secondary metabolism.


Sujet(s)
Anthraquinones , Protéines bactériennes , Streptomyces coelicolor , Anthraquinones/métabolisme , Streptomyces coelicolor/métabolisme , Streptomyces coelicolor/génétique , Protéines bactériennes/métabolisme , Protéines bactériennes/génétique , Famille multigénique , Mutation , Benzoisochromanequinones
16.
Bioresour Technol ; 411: 131333, 2024 Nov.
Article de Anglais | MEDLINE | ID: mdl-39181514

RÉSUMÉ

In this study, electron transport pathways were activated and diversified by coupling counter-diffusion biofilms with micro-electrolysis for Alizarin yellow R (AYR) denitrogenation. Due to the binding of AYR to two residues of EC 4.1.3.36 with higher binding energy, the expression of EC 4.1.3.36 was down-regulated, causing the EC 3.1.2.28 and EC 2.5.1.74 for menaquinone synthesis (redox mediator) undetectable in Membrane aerated biofilm reactors (MABR). Spontaneous electron generation in the micro electrolysis-coupled MABR (ME-MABR) significantly activated two enzymes. Activated menaquinone up-regulated decolourisation related genes expression in ME-MABR, including azoR (2.12 log2), NQO1 (2.97 log2), wrbA (0.45 log2), and ndh (0.47 log2). The diversified electron flow pathways also promoted the nitrogen metabolism coding genes up-regulation, accelerating further inorganic nitrogen denitrogenation after AYR mineralisation. Compared to MABR, the decolourisation, mineralisation, and denitrogenation in ME-MABR increased by 25.80 %, 16.53 %, and 13.32 %, respectively. This study provides new insights into micro-electrolysis enhanced removal of AYR.


Sujet(s)
Biofilms , Électrolyse , Composés azoïques/métabolisme , Composés azoïques/composition chimique , Agents colorants/métabolisme , Agents colorants/composition chimique , Bioréacteurs , Diffusion , Anthraquinones/métabolisme , Azote , Dépollution biologique de l'environnement
17.
Int J Biol Macromol ; 277(Pt 4): 134472, 2024 Oct.
Article de Anglais | MEDLINE | ID: mdl-39102924

RÉSUMÉ

Chronic inflammation and infection often lead to delayed healing in skin wounds of patients with diabetes, presenting a significant challenge in clinical wound repair. In an effort to tackle this issue, we explored the utilization of the natural compounds Rhein and chitosan in the creation of a crosslinked in situ gel. Developed as Rhein-chitosan in situ hydrogel (CS-Rh gel), this formulation has the ability to gel at body temperature, making it suitable for irregular wounds of varying shapes. Our experimental investigations have demonstrated its excellent biocompatibility, controlled release of Rhein, biodegradability, anti-inflammatory properties, antibacterial effect, as well as its ability to enhance keratinocyte proliferation and migration. Furthermore, in vivo studies have confirmed that CS-Rh gel can effectively mitigate tissue inflammation, promote collagen deposition, and significantly accelerate wound healing in diabetic mice within a short timeframe of two weeks. Consequently, this innovative approach holds promise as a viable therapeutic strategy for supporting the healing of diabetic wounds in a clinical setting.


Sujet(s)
Anthraquinones , Chitosane , Diabète expérimental , Hydrogels , Cicatrisation de plaie , Chitosane/composition chimique , Chitosane/pharmacologie , Animaux , Cicatrisation de plaie/effets des médicaments et des substances chimiques , Souris , Diabète expérimental/traitement médicamenteux , Hydrogels/composition chimique , Hydrogels/pharmacologie , Anthraquinones/pharmacologie , Anthraquinones/composition chimique , Humains , Prolifération cellulaire/effets des médicaments et des substances chimiques , Antibactériens/pharmacologie , Antibactériens/composition chimique , Mâle , Anti-inflammatoires/pharmacologie , Anti-inflammatoires/composition chimique , Mouvement cellulaire/effets des médicaments et des substances chimiques , Kératinocytes/effets des médicaments et des substances chimiques
18.
J Hazard Mater ; 478: 135464, 2024 Oct 05.
Article de Anglais | MEDLINE | ID: mdl-39141945

RÉSUMÉ

The growing utilization of Traditional Chinese Medicine (TCM) has resulted in an increase in wastewater. Herein, a new kind of organic-inorganic redox mediator membrane by immobilizing γ-FeO(OH) and aloe-emodin(AE) with the characteristic large π-conjugation anthraquinone structure on PVDF membrane was innovatively achieved. AE exhibiting both electron deficiency and redox activity possesses a co-catalyst role in degradation of tannic acid (TA), aiding in the separation of charge carriers through the sequential hydrogenation and dehydrogenation of AE. The removal rates of TA were 92.8 % in the tannic acid solution and 60.3 % in the simulated rhubarb wastewater by the AE-γ-FeO(OH) membrane under PMS+Vis conditions in 45 min. Also, they show a higher recovery of pure water flux and owning good fouling performance. Overall, this current work presents a novel approach for the design and preparation of organic-inorganic photocatalytic composite membrane using readily available natural products for the purification TCM wastewater.


Sujet(s)
Anthraquinones , Membrane artificielle , Oxydoréduction , Tanins , Polluants chimiques de l'eau , Tanins/composition chimique , Anthraquinones/composition chimique , Catalyse , Polluants chimiques de l'eau/composition chimique , Eaux usées/composition chimique , Purification de l'eau/méthodes , Rheum/composition chimique , Élimination des déchets liquides/méthodes , Polyphénols
19.
Microb Biotechnol ; 17(9): e70002, 2024 Sep.
Article de Anglais | MEDLINE | ID: mdl-39212141

RÉSUMÉ

To date, there are no real physiological mechanisms for iron excretion in eukaryote, and no physiological "actuator" that can control all the three fundamental biologic processes of absorption, storage, and excretion. Here, we observed that the accumulation of anthraquinones by Thermomyces dupontii under cold stress can achieve this process. Through mutation analysis, we found that mutant ΔAn deficiency in anthraquinones accumulated ferrous and total free iron due to adopting a rare lifestyle with no endocytosis but accumulation of membrane-derived vesicles. Anthraquinone complement indicated that the vesicles in ΔAn could coat the extrinsic anthraquinone-induced granules to prevent contact with the fungal interiors. Detailed chemical investigation on ΔAn led to characterization of a rare oxygen-free ergosterene with unstable nature in air as the major membrane steroid in ΔAn, suggesting hypoxia inner in ΔAn cells, consistent with dramatically low oxygen-consuming rates in ΔAn. A series of physiological and metabolic analyses indicated anthraquinones were involved in exporting ferrous and promoting formation of oxygen-containing metabolites, including ergosterols for endocytosis and iron chelators for iron storage. Moreover, we found that both the anticancer agent mitoxantrone with well-known-cardiotoxicity side effect and the major terpenoid-derived polycyclic aromatics from Danshen for treating cardiovascular disease showed potent ferrous transporting capabilities in human cancer cells. Our findings provide a novel insight into the underlying mechanisms of polycyclic aromatics in nature and pharmacology, and offer a new strategy for developing potential therapeutics and agents for membrane transport, iron homestasis, and anticold.


Sujet(s)
Anthraquinones , Endocytose , Fer , Anthraquinones/métabolisme , Fer/métabolisme , Humains , Réponse au choc froid , Stérols/métabolisme
20.
J Nat Med ; 78(4): 929-951, 2024 Sep.
Article de Anglais | MEDLINE | ID: mdl-39103726

RÉSUMÉ

Fungi, such as Trichophyton rubrum (T. rubrum) and Microsporum canis Bodin Anamorph (M. canis Bodin Anamorph) are the main pathogens of dermatophysis. According to ancient books records, Rumex japonicus Houtt. (RJH) has a miraculous effect on the treatment of dermatophysis. To reveal the anti-fungi (T. rubrum and M. canis Bodin Anamorph) components and its mechanism of the Rumex japonicus Houtt. The vinegar extraction and alcohol precipitation, HPLC and nuclear magnetic resonance spectroscopy (NMR) were employed for analyzing the chemical compositions of RJH; in vitro anti-fungal experiment was investigated including test the minimum inhibitory concentration (MIC) and the minimum fungicidal concentration (MFC), spore germination rate, nucleic acid, protein leakage rate, biofilm structure, and the mechanism of anti-fungal and anti-fungal biofilms in RJH. Seven anthraquinones and their glycoside compounds were obtained in this study respectively, such as chrysophanol, physcion, aloe-emodin, emodin, rhein, emodin-8-O-ß-D-glucoside and chrysophanol-8-O-ß-D-glucoside. In vitro anti-fungal experiment results showed that RJH extracts have good anti-fungal activity for dermatophytic fungi. Among them, the MIC of the rhein, emodin and aloe-emodin against T. rubrum are 1.9 µg/ml, 3.9 µg/ml and 15.6 µg/ml, respectively; the MIC of emodin and aloe-emodin against M. canis Bodin Anamorph are 7.8 µg/ml and 62.5 µg/ml, respectively. In addition, its active components can inhibit fungal spore germination and the formation of bud tube, change cell membrane permeability, prevent hyphal growth, destroy biofilm structure, and down-regulate the expression of agglutinin-like sequence family 1 of the adhesion phase of biofilm growth. The study shows that RJH play a fungicidal role.


Sujet(s)
Anthraquinones , Antifongiques , Biofilms , Hétérosides , Tests de sensibilité microbienne , Microsporum , Rumex , Anthraquinones/pharmacologie , Anthraquinones/composition chimique , Anthraquinones/isolement et purification , Rumex/composition chimique , Antifongiques/pharmacologie , Antifongiques/composition chimique , Antifongiques/isolement et purification , Hétérosides/pharmacologie , Hétérosides/composition chimique , Microsporum/effets des médicaments et des substances chimiques , Biofilms/effets des médicaments et des substances chimiques , Extraits de plantes/pharmacologie , Extraits de plantes/composition chimique , Émodine/pharmacologie , Émodine/composition chimique , Émodine/analogues et dérivés , Arthrodermataceae
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE